MarketPeel
Insider Trading Intelligence
Pricing
…
CC

Cooper C. Collins

TXMD
DIRECTOR · THERAPEUTICSMD, INC. · CIK 0001485508
FILING MIX · LIFETIME83%/17%
BUYS
15
SELLS
3
TOTAL VALUE
$1.42M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
8,500
AVG SELL PX
—
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Cooper C. Collins, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+71.43%+3.95%-0.63%+4.58%+5.78%—
14d7+57.14%-3.80%-0.96%-2.84%+1.94%—
30d7+42.86%-4.23%+0.09%-4.31%-4.27%—
60d7+42.86%-4.60%+2.69%-7.29%-6.78%—
90d7+0.00%-21.57%+4.44%-26.01%-25.76%—
180d7+0.00%-46.89%+5.65%-52.54%-52.36%—
1y7+0.00%-45.48%+11.39%-56.86%-54.26%—
2y7(2 pending)+0.00%-88.98%+12.50%-101.48%-92.04%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TXMD · 8,500 shares · as of Nov 3, 2025
0559,2161,118,4321,677,6482,236,86420212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 15 buys / 3 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Nov 3, 2025Nov 5, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
8,500——60,516Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
8,500——0Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
4,094$1.73$7.1K52,016Aug 22, 2024Aug 26, 2024 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
1,200$1.70$2.0K47,922Aug 21, 2024Aug 23, 2024 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Jul 17, 2023Jul 19, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Sep 29, 2022Oct 3, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
1,984——46,722Aug 18, 2022Aug 22, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
1,984——0Aug 18, 2022Aug 22, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
1,000,000$0.58$578.5K2,236,864Nov 18, 2021Nov 22, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
900,000$0.72$648.0K1,236,864Aug 18, 2021Aug 19, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
100,000$0.77$77.0K336,864Aug 17, 2021Aug 19, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
96,864——0Aug 10, 2021Aug 12, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
96,864——236,864Aug 10, 2021Aug 12, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
99,174——99,174Jul 1, 2021Jul 2, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
96,864——96,864Jun 18, 2020Jun 19, 2020 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
47,500$1.45$68.9K140,000Jun 9, 2020Jun 10, 2020 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
26,500$1.45$38.4K92,500Jun 8, 2020Jun 10, 2020 ↗View →
Other insiders · TXMD
Loading peer insiders…
About this filer
CIK 0001485508
ROLE
Director
PRIMARY
TXMD
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001485508DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback